TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: parental knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean pain reduction from baseline at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving ≥30% reduction in pain at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving ≥50% reduction in pain at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCEA bolus consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop in total cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drop in LDL-cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drop in triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Age as an independent risk factor of AT1 receptor autoantibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained DAS28 low disease-activity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained remission rates at week 104
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Power (TP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Very Low Frequency Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach 7 mm pupil dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMR-derived ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean rate of pressure rise (dP/dt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful IAT response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Development of sinusitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tdap vaccine effectiveness in preventing pertussis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in palpation and identification of soft tissue landmarks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower pre-contact amplitude of the peroneus longus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: activation timing of anterior tibialis, peroneus longus, rectus femoris, and gluteus medius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: percentage of stride cycle activation of peroneus longus and rectus femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HF re-hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Development of new hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death from pericarditis
Endpoint domain: Mortality/survival
Primary endpoint: break-up of a marriage
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: break-up of a sexual relationship
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Willingness to complete a depression screen
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived value of depression screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-36 Physical Function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nausea severity score
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: mean ACT score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CACT score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean NQ score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Downtime (continuous renal replacement therapy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximal oxygen uptake (o2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of metabolic syndrome risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical leg alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint line level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellar height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schiff scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caring Ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive Attitudes towards Suicidal Individuals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in TSP1 serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VEGFR1 serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating angiogenic balance (TSP1/VEGF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of erythema secondary to vasodilatation
Endpoint domain: Adverse events/effects
Primary endpoint: mean expiratory tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of postnatal depression (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified DLQI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxford self-assessment score results
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional impairment from pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAN-PSS-1 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUCt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical improvement in asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of age eligible patients tested
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of newly identified HIV positive patients referred to care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of newly identified HIV positive patients entering on-site care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of anastomotic strictures
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate on the Hamilton anxiety scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerosol distribution within the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Deposition in smaller vs larger airways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cognition classification accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage flow-mediated dilatation (%FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal Index (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean maximum plasma concentration of misoprostol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean area under the concentration‐versus‐time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean disappearance half‐life of misoprostol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decrease in visual analogue scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of donor site pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain scores at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cost for heart failure patients
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in passive C1-2 rotation range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Physical Health subscore of the SF-36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rehospitalizations for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in GNDS points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily life disturbance score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence rate of complications
Endpoint domain: Adverse events/effects
Primary endpoint: CMJ performance recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPT (Pain Pressure Threshold)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperglycemic rescue rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clearance of Salmonella from stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mean change in RB staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluorescein clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in blurred vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cleansing effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective wake time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Clinically significant improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Heart rate-corrected velocity of circumferential fiber shortening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CD8+ HLADR+ cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: NK cell recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: safety and preliminary efficacy
Endpoint domain: Adverse events/effects
Primary endpoint: Curative effect of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache scores and VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache attack duration during menstruation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for FLP over CIC nasal spray
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mild headache following administration
Endpoint domain: Adverse events/effects
Primary endpoint: Total adhesiolysis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EMG amplitude of abdominal oblique muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive functioning perception
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PACQLQ scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative maternal TAC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical artery TAC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative maternal TOS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New syndesmophytes development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of needle insertions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of acute fluid overload (AFO) or CV-related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of intra-dialysis morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of performance (expert-based ratings)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reduction of pad weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of pads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nocturia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with vaginal dilation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean joint score for accurate decisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of program adoption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ejaculation control scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ejaculation-related personal distress scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Language scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral mucositis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in communication between families and staff
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Reduced conflict with families
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in behavioral symptoms for residents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma adrenomedullin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of metamorphopsia and scotoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of PHP test in geographic atrophy and neovascular ARMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall mark
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Failure rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rating of educators
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in osteoarthritis severity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of NOMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of influenza vaccination refusal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in AL prescription among patients with negative malaria results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in median polyp size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of late PV reconnection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to resolution of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Ketamine-Associated Vomiting (KAV)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean time to resumption of normal diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daylight activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative amplitude of the sleep-wake cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and intensity of shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost of diagnostic procedures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean progression of erosion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPI at 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR20 criteria response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PsARC achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission status after one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychiatric symptoms (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural function recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of C5 palsy
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of infants with anti-PRP levels >=0.15 microg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of infants with serum bactericidal antibody (SBA) titre >=1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: copper absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained clearance of HCV viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Physician advised postpartum oral glucose tolerance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone density in post-extraction socket
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first acute exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage of subjects requiring hospitalization for exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in cancer risk behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictability in detecting persistent asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: apparent volume of central compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absorption rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular EC50 of sevoflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ST-segment resolution at 4 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reinfarction rates
Endpoint domain: Adverse events/effects
Primary endpoint: 30 day death/(re)MI
Endpoint domain: Mortality/survival
Primary endpoint: EC50 for I-gel insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC95 for I-gel insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician global assessment improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient global assessment score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: task accuracy regarding attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transitory hypoparathyroidism
Endpoint domain: Adverse events/effects
Primary endpoint: satisfactory outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute risk reduction in invasive IBEs
Endpoint domain: Mortality/survival
Primary endpoint: Relative risk reduction of invasive IBEs
Endpoint domain: Mortality/survival
Primary endpoint: Number of contralateral events
Endpoint domain: Adverse events/effects
Primary endpoint: TCM diagnosis influence on treatment delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak VO2 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: haemodilution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correction of hypervolaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes